I Sent 340 Post-Menopausal Women Toward Fillers for Their Jaw. Then I Read the Data I Should Have Read First.
Every protocol I used addressed the wrong layer. The muscle oestrogen decline had weakened. The research showing this existed the whole time.
Twelve years of the same protocol. Every option I recommended missed the one layer that mattered for post-menopausal jaw changes. This is what I should have read before I recommended any of them.
In twelve years of practice I recommended fillers to approximately 340 patients for jaw laxity. Threads to perhaps 180. Surgical consultation to 94. The majority of them were post-menopausal. I kept detailed records. What I did not record — because I was not looking for it — was how many came back.
Most of them did. That is the part I should have paid attention to earlier.
The pattern I was missing was hormonal. Every patient who kept returning had one thing in common: the jaw changes had accelerated after menopause.
Here is what I recommended, and what each option actually does:
I recommended all three — repeatedly, to hundreds of patients — before I understood why none of them were resolving the problem at its source.
The source — particularly in post-menopausal women — is not the skin. The source is the platysma: the muscle oestrogen had been maintaining.
Every Option I Named Addressed the Same Layer. None of Them Could Reach the One Oestrogen Decline Had Weakened.
The jaw falls for one primary reason that fillers, threads and every topical treatment fail to address: the platysma and the deeper facial muscles lose the hormonal support oestrogen provided — and atrophy.
After menopause, oestrogen withdrawal accelerates this process. The platysma — the broad muscle running from chest to jaw — loses tone it cannot recover without direct stimulation. The skin above follows. The jaw slides.
Each option treats what is visible above the muscle — not the muscle itself.
Surgery addresses both layers — skin and underlying tissue — which is why it works. But it is a permanent commitment on a face that will continue to age beneath the incision.
What addresses the muscle layer without surgery is microcurrent — a low-level electrical current that passes directly through the skin to the muscle beneath, stimulating contraction and rebuilding tone the same way a physiotherapist uses electrical stimulation to rebuild an atrophied limb muscle after injury.
Combined with red light at 630nm — which supports collagen production in the dermis above — you are addressing both layers a surgical facelift addresses. Without the incision. Without the recovery. Without the permanence.
"I knew this technology existed. I dismissed it because the clinic version and the at-home version looked categorically different to me. I was wrong about that — and I was especially wrong for post-menopausal patients, where the mechanism is exactly what they need."
— Dr. Erica AdamsI had been dismissing the at-home category for twelve years — and recommending procedures to post-menopausal women whose underlying muscle atrophy those procedures could not address. The devices looked like consumer products. The marketing made them sound like ones. And I had not read the independent clinical data — not because it wasn't there, but because I had already decided the answer.
The Mechanism I Had Been Dismissing — and What the Research Actually Said About Post-Menopausal Jaw Laxity.
I reviewed the independent clinical data on the underlying technology the same way I review any study I intend to cite. The focus: whether it addressed the muscle layer — the one oestrogen withdrawal had compromised in the patients I kept sending back for repeat procedures.
Independent researchers. No brand funding. Skin measured directly — not self-reported. Thirty days of consistent use.
I looked for a methodological reason to set it aside. I couldn't find one.
I then compared the device specifications against the clinic-grade microcurrent equipment I use in professional settings. — 630nm red light, EMS microcurrent at the same therapeutic frequencies. The difference is the clinic overhead, the brand name, and the margin built into every session.
A single clinic microcurrent session: $250–$500.
The Survora Halo, with a 60-night money-back guarantee: a fraction of the cost of one appointment.
I ordered one and documented the results as I would any clinical observation. I had gone through menopause at 53. My jaw had been the clinical problem I had been referring others to treat for three years.
Week One: No Measurable Change. Week Three: First Observable Difference. Week Five: Independent Confirmation.
Patient documentation. Same clinic, same lighting, same angle. Three appointments over five weeks.
I ran a concurrent patient trial. One patient, 61, post-menopausal for eight years, had been pricing a lower facelift and agreed to delay the consultation by five weeks. Same clinic. Same lighting. Same angle. Weeks one, three and five.
I used the device on myself for the same period. Five minutes each morning. No other variable changed.
No measurable change. Expected. Muscle conditioning does not produce visible results in seven days.
First observable difference in the clinical photographs. Jaw angle marginally more defined. Documented. Inconclusive at this stage — I required external confirmation.
A colleague I have worked alongside for eleven years stopped me in the clinic corridor. She had no knowledge of the trial. She asked if I had done something. She could not name what.
She had not told him anything. He simply asked.
Two people. No prompting. No shared information. Neither aware the other had said anything.
I had spent twelve years telling patients the muscle layer was unreachable without surgery. Two unsolicited observations in the same week told me I had been wrong.
That is what changed my protocol. Not a feeling. Not self-reported results. Two people who had nothing to gain from saying what they said.
What I Should Have Told 340 Post-Menopausal Patients Before I Said Anything Else.
I changed my protocol. Not because of one test. Because the mechanism is sound, the independent data is clean, the technology is the same as the clinic version, and the result — across my own observation and a documented patient trial — matched what the data predicted.
Before any post-menopausal patient books a jaw consultation with me now, I ask them to complete sixty days of consistent device use first.
The clinical rationale is straightforward:
Surgery, fillers and threads all carry cost, commitment and in some cases recovery. If the muscle layer can be addressed non-invasively first, that changes the calculus entirely. The procedure may not be necessary. And if it is, sixty days of data gives us a clearer baseline for what the procedure needs to accomplish.
That is the Survora Halo.
Survora Birthday Sale — Limited Time
Wrong Protocol.
For Post-Menopausal Jaw.
The data was there. I wasn't reading it. If you're post-menopausal and pricing a procedure for your jaw right now, try this first — sixty nights, full refund if it doesn't work, and the procedure will still be there if you need it.
SEE THE DATA — AND WHAT I NOW RECOMMEND FIRST
Free activator gel · 60-night guarantee · Free USA shipping
★★★★★4.7 average · 1,000+ reviews · 60,000+ Happy Customers
Fillers address the dermis. Threads address the skin surface. Neither reaches the platysma beneath — which is where post-menopausal jaw laxity originates, as oestrogen withdrawal removes the hormonal support the muscle depends on.
Surgery addresses both layers. Microcurrent addresses the muscle layer without the incision, the recovery, or the permanence.
The clinical mechanism is the same. The procedure is not.
I had dismissed this category before reading the data — including data specifically relevant to post-menopausal muscle atrophy. That was the error.
Independent researchers. Thirty days. Skin measured directly. I could not find a methodological reason to dismiss it.
I compared the device specifications against the professional clinic equipment I use in practice.
The difference is the overhead, the brand name, and the margin.
One clinic microcurrent session: $250–$500. The Halo: a fraction of that, with a 60-night money-back guarantee.
Surgery is permanent. Filler requires ongoing maintenance. Threads dissolve and cannot be repeated indefinitely.
This commits to five minutes a day and a 60-night trial. Full refund if it doesn't produce a measurable result. The surgical option remains available at the end of sixty nights if you need it. What changes is that you'll have data on whether you actually do.
That is the honest clinical record. The independent data on microcurrent and red light — and its relevance to post-menopausal muscle atrophy — existed before I dismissed the category.
I am recommending this now because the mechanism is sound, the data is clean, and the result matched the prediction.
"I had a facelift consultation booked. I'd gone through menopause at 58 and my jaw changed almost immediately. I'd done creams, a NuFACE that died in a drawer, a thread lift that lasted eight months. Five weeks with this and my husband asked what I'd done differently. I cancelled the appointment."
"I've been using the Halo every evening for about five weeks, and my jawline is so much firmer. I'm 61, post-menopausal, and the sag under my chin is nearly gone. I used to spend a fortune on clinic facials — this does the same for a fraction of the cost."
"Three weeks in. I hadn't. Just this, every night. I genuinely did not expect it to work and I'm still a little shocked that it did."
"I've recommended this to all my friends because the results have been incredible. My jowls are practically gone. Five minutes a day and my jawline looks years younger — I didn't think that was possible without surgery."
The Data Was There. I Dismissed It for Twelve Years — While Recommending Procedures to Post-Menopausal Women.
I still use the device most mornings. That is the honest limitation. This is not a one-time procedure. It requires daily consistency the same way any muscle-conditioning protocol does — and for post-menopausal jaw laxity, that consistency is what produces the result.
What I cannot change is twelve years of sending post-menopausal patients toward fillers, threads and surgical consultations before exhausting the non-invasive option — before addressing the muscle layer oestrogen decline had already weakened. The data existed. I had not read it. That is the honest clinical record.
If you are post-menopausal and currently pricing a jaw procedure, I am asking you to complete sixty days of this first. Not instead of the procedure. Before it.
The clinical rationale: if the muscle layer can be addressed non-invasively, the procedure may not be necessary. If it is still necessary after sixty days, you will have a clearer baseline and a more precise picture of what the procedure needs to accomplish. The data improves either outcome.
The surgical option will still be there after sixty nights.
I recommended 340 patients — most of them post-menopausal — toward fillers before I read this data. If you are one of the women who came back asking what comes next — this is what comes next.
Survora Birthday Sale — Limited Time
I Wasn't Reading It.
Twelve years of the wrong protocol — for post-menopausal jaw changes that fillers and threads could never reach. If you're pricing a procedure, try this first — sixty nights, full refund if it doesn't work.
SEE THE DATA — AND WHAT I NOW RECOMMEND FIRST
Free activator gel · 60-night guarantee · Free USA shipping
★★★★★4.7 average · 1,000+ reviews · 60,000+ Happy Customers